Short: Once recurrent pancreas cancer has been defined and fails to respond to chemo the prognosis is short lived. Chemo such as Gemzar (gemcitabine) and Abraxane have added about 3-5 months to survival. New monoclonals are in study which may bring this process under better control
Answered 6/18/2018
4k views
A doctor has provided 1 answer
A doctor has provided 1 answer
6 doctors weighed in across 2 answers
A doctor has provided 1 answer
90,000 U.S. doctors in 147 specialties are here to answer your questions or offer you advice, prescriptions, and more.
Ask your question